Denali Therapeutics Inc. (MUN:4DN)
Germany · Delayed Price · Currency is EUR 17.21
0.00 (0.00%)
At close: Dec 4, 2025
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of €2.16 billion as of December 15, 2025. Its market cap has decreased by -36.94% in one year.
Market Cap
2.16B
Enterprise Value
1.46B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€17.21
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from 1.61B to 2.16B, an increase of 34.71%. That is a compound annual growth rate of 3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 2.16B | -23.67% |
| Dec 31, 2024 | 2.83B | 5.59% |
| Dec 29, 2023 | 2.68B | -24.08% |
| Dec 30, 2022 | 3.53B | -26.21% |
| Dec 31, 2021 | 4.79B | -41.67% |
| Dec 31, 2020 | 8.21B | 450.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.47B |
| Siemens Aktiengesellschaft | 184.54B |
| Allianz SE | 145.75B |
| Deutsche Telekom AG | 127.52B |
| Siemens Energy AG | 101.53B |
| Rheinmetall AG | 72.19B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.46B |
| Deutsche Bank Aktiengesellschaft | 61.07B |